Clinical Trial Update: Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating the combination of capecitabine and oxaliplatin in patients with metastatic breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED